IMMAGINA BIOTECHNOLOGY and TomaLab are excited to host a series of free live scientific webinars. During the webinars, prestigious speakers will present their recent researches carried out by the use of IMMAGINA BIOTECH products for the study of translational control of gene expression and diseases.
We are working together to develop a powerful data analysis tool for the only product available for 3’ phospho-RNA sequencing with ONT platform, CircAID-p-seq! Genexa is a service provider for bioinformatic analyses based in Zurich, Switzerland. Genexa’s services are centered around the analysis of third- and next-generation genomics data and the development of novel data […]
We are excited to share our
Immagina Ribo-Omics Grant Challenge 2020.
Win up to €5,000 of Immagina® products!
We are glad to announce that we were awarded the EIT headstart grant to further investigate circAID-p-seq applications in the pharma sector
One-shot analysis of translated mammalian lncRNAs with AHARIBO
In February 2020 IMMAGINA raised 1 M Euro from existing investors and new, undisclosed EU-based investors. The Company has raised about 2 M Euro to date
Our preprint work describing new probes to sense the activity of protein synthesis and to capture associated RNA is now available on bioRxiv
The Next Tech – World Cancer Day And local media are sometimes important to help the local business community…
Our first paper reporting the basic of our RiboLace technology Active ribosome profiling with RiboLace is now public available on bioRxiv. The paper describes a novel method based on an original puromycin-containing molecule capable of isolating active ribosomes by means of an antibody-free and tag-free pull-down approach. RiboLace is fast, works reliably with low amounts of input material, […]
Viero’s Lab published In vivo translatome profiling reveals early defects in ribosome biology underlying SMA pathogenesis in bioRxivpreprint. The results described suggest that neuronal tissues and cells are particularly sensitive to perturbations in translation during SMA, and identify ribosome biology as an important, yet largely neglected, factor in motor neuron degeneration